1. Home
  2. IVA vs WNC Comparison

IVA vs WNC Comparison

Compare IVA & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • WNC
  • Stock Information
  • Founded
  • IVA 2011
  • WNC 1985
  • Country
  • IVA France
  • WNC United States
  • Employees
  • IVA N/A
  • WNC N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • IVA Health Care
  • WNC Industrials
  • Exchange
  • IVA Nasdaq
  • WNC Nasdaq
  • Market Cap
  • IVA 359.6M
  • WNC 425.6M
  • IPO Year
  • IVA 2020
  • WNC 1991
  • Fundamental
  • Price
  • IVA $3.07
  • WNC $10.54
  • Analyst Decision
  • IVA Strong Buy
  • WNC Hold
  • Analyst Count
  • IVA 4
  • WNC 1
  • Target Price
  • IVA $10.50
  • WNC $9.50
  • AVG Volume (30 Days)
  • IVA 27.3K
  • WNC 605.8K
  • Earning Date
  • IVA 03-26-2025
  • WNC 07-23-2025
  • Dividend Yield
  • IVA N/A
  • WNC 3.05%
  • EPS Growth
  • IVA N/A
  • WNC N/A
  • EPS
  • IVA N/A
  • WNC N/A
  • Revenue
  • IVA $14,591,573.00
  • WNC $1,812,354,000.00
  • Revenue This Year
  • IVA $15.38
  • WNC N/A
  • Revenue Next Year
  • IVA $24.22
  • WNC $18.83
  • P/E Ratio
  • IVA N/A
  • WNC N/A
  • Revenue Growth
  • IVA N/A
  • WNC N/A
  • 52 Week Low
  • IVA $1.53
  • WNC $6.78
  • 52 Week High
  • IVA $4.05
  • WNC $24.03
  • Technical
  • Relative Strength Index (RSI)
  • IVA 39.40
  • WNC 57.59
  • Support Level
  • IVA $3.25
  • WNC $10.01
  • Resistance Level
  • IVA $3.47
  • WNC $10.68
  • Average True Range (ATR)
  • IVA 0.23
  • WNC 0.40
  • MACD
  • IVA -0.04
  • WNC 0.06
  • Stochastic Oscillator
  • IVA 8.51
  • WNC 70.39

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: